Five symptoms captured much of the signal in youth depression screening
A set of 5-item short forms drawn from widely used youth depression measures performed with surprising consistency across a large, racially diverse clinical sample. Investigators extracted five symptom domains — low mood, poor concentration, low self-worth, loss of interest, and low energy — from four established tools and asked whether those brief versions could stand in for the longer instruments without losing too much diagnostic value.
The question matters because pediatric mental health visits often move quickly, and every extra minute spent on symptom inventories competes with interview time, safety assessment, and treatment planning. Brief measures only help if they still track the underlying disorder with enough fidelity to inform decisions. Here, the abbreviated forms held up well against their full-length counterparts and against diagnostic outcomes established through semi-structured interviews and LEAD consensus.
Correlation with the full instruments remained strong across four scales
The short forms were built from the Child Behavior Checklist, Youth Self Report, Parent General Behavior Inventory, and Adolescent General Behavior Inventory. Across those four instruments, the 5-item versions correlated highly with the original scales, with coefficients ranging from 0.74 to 0.92. Inter-item correlations also stayed in a range that suggests the items were related without collapsing into redundancy, spanning 0.19 to 0.46.
Those numbers matter because they suggest the abbreviated measures preserved the core symptom signal rather than simply trimming away noise. In depression assessment, the balance is delicate: too few items and the measure becomes brittle, too many and clinicians stop using it. The investigators appear to have landed on a compact set of symptoms that still moved in step with the broader scales.
The sample included 1,185 youth from community and academic outpatient mental health settings, with 48% Black participants. That breadth strengthens the practical relevance of the findings, since youth depression screening often has to work outside tightly controlled research cohorts. The short forms did not differ meaningfully from the full measures in their correlations with psychiatric diagnoses, demographic characteristics, or diagnostic interview findings.
Diagnostic performance was fair to good, with one notable exception
The more clinically consequential test was whether the short forms could identify depression and any mood disorder diagnosis. Area under the curve values for those outcomes ranged from 0.60 to 0.79, a spread that lands in the fair-to-good range for screening purposes. Four of the abbreviated measures — the CBCL-5, YSR-5, P-GBI-5, and A-GBI-5 — were not meaningfully worse than their full-length versions, except for the parent-reported GBI short form, where performance did not hold up as well.
The pattern is clinically intuitive. Depression in youth often presents through overlapping affective, cognitive, and energy-related symptoms, and a small set of carefully chosen items can still capture a meaningful portion of that phenotype. Loss of interest, low mood, low self-worth, poor concentration, and low energy are common anchors across depressive syndromes, and these symptom domains may be especially efficient because they cut across age and setting without relying on a long checklist of less central complaints.
AUC values in the 0.60 to 0.79 range do not suggest a stand-alone diagnostic instrument. They do suggest a useful screener, especially when the goal is to decide who needs a fuller evaluation rather than to make a final diagnosis from a questionnaire alone. In pediatric settings, that distinction has direct operational value: a short form can help triage attention toward youth who may need a longer interview, collateral input, or closer follow-up.
Why five core symptoms may be enough for first-pass screening
The emphasis on core depressive symptom domains echoes adult work showing that the same five symptoms can be sensitive to treatment effects. In youth, the present findings suggest those domains also retain screening utility. Biologically and clinically, that makes sense. Low mood and anhedonia reflect the emotional core of depression, while diminished energy, impaired concentration, and low self-worth often map onto the functional burden that drives help-seeking and school impairment.
Short forms work best when they retain the symptoms most likely to shift with illness severity and most likely to appear across developmental stages. A child’s depressive presentation can look different from an adult’s, but the underlying syndrome still frequently expresses itself through disengagement, fatigue, cognitive slowing, and negative self-appraisal. Compressing those domains into five items may preserve the signal clinicians care about most during routine screening.
The findings also speak to measurement efficiency in busy clinics. When screening becomes easier to complete and interpret, it is more likely to be used repeatedly, which matters for longitudinal monitoring. For child and adolescent psychiatry, repeated measurement is often the only practical way to detect worsening symptoms, response to treatment, or a need to revisit the diagnosis.
The parent-report form needs the most caution
One result stood apart: the P-GBI-5 did not perform as favorably as the other short forms relative to its full-length version. The abstract does not offer a deeper breakdown of why that happened, but parent-report scales can behave differently from youth self-report tools because parents observe distress indirectly, through sleep, school functioning, irritability, or withdrawal, rather than through internal experience itself. A shortened parent form may lose some of that nuance.
That issue matters in practice because pediatric depression assessment often depends on multiple informants. A tool that works well in self-report may not translate identically when filled out by caregivers. The parent form therefore looks more like a candidate for further validation than a finished replacement for the original scale.
What this preprint supports, and what it still cannot prove
This is a preprint, so the findings remain preliminary and should not be used to redirect clinical practice on their own. Even so, the design was anchored in a large sample, a diverse patient population, and diagnostic confirmation through semi-structured interviews and LEAD consensus, which gives the results real weight as measurement evidence.
The most important next step is not whether these five-item tools correlate with the full versions — they already do — but whether they can function as outcome measures during treatment. Screening and monitoring are related but not identical tasks. A measure that can identify likely depression at intake may still fail to capture symptom change with the same precision over time, especially when small but meaningful improvements must be detected in children and adolescents receiving care.
For now, the study supports a restrained but practical conclusion: four brief youth depression measures appear capable of preserving much of the diagnostic information in their longer forms, and they may fit better into real-world outpatient workflows than lengthier questionnaires. The unresolved issue is their performance as treatment endpoints, where sensitivity to change will determine whether brevity comes at the cost of clinical usefulness.